NEAT1: A novel cancer-related long non-coding RNA
- PMID: 28105699
- PMCID: PMC6529067
- DOI: 10.1111/cpr.12329
NEAT1: A novel cancer-related long non-coding RNA
Abstract
Aberrant overexpression of the long non-coding RNA NEAT1 (nuclear paraspeckle assembly transcript 1) has been documented in different types of solid tumours, such as lung cancer, oesophageal cancer, colorectal cancer and hepatocellular carcinoma, in which its high levels are associated with poor prognosis. In contrast, NEAT1 is downregulated in acute promyelocytic leukaemia where it promotes leucocyte differentiation. In this review, we provide an overview of current evidence concerning the oncogenic role and potential clinical utilities of NEAT1. Further investigations are warranted to elucidate the upstream and downstream mechanisms of NEAT1 overexpression.
© 2017 John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no competing financial interests.
Figures
References
-
- Li CH, Chen Y. Targeting long non‐coding RNAs in cancers: progress and prospects. Int J Biochem Cell Biol. 2013;45:1895–1910. - PubMed
-
- Costa FF. Non‐coding RNAs: new players in eukaryotic biology. Gene. 2005;357:83–94. - PubMed
-
- Shi X, Sun M, Liu H, Yao Y, Song Y. Long non‐coding RNAs: a new frontier in the study of human diseases. Cancer Lett. 2013;339:159–166. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
